$SMG
SCOTTS MIRACLE-GRO CO

2012 Q1 Form 10-Q Financial Statement

#000154638013000012 Filed on May 07, 2013

View on sec.gov

Income Statement

Concept 2012 Q1
Revenue $1.170B
YoY Change 418.56%
Cost Of Revenue $708.5M
YoY Change 291.22%
Gross Profit $461.7M
YoY Change 827.11%
Gross Profit Margin 39.45%
Selling, General & Admin $236.9M
YoY Change 83.08%
% of Gross Profit 51.31%
Research & Development $12.10M
YoY Change -2.42%
% of Gross Profit 2.62%
Depreciation & Amortization $14.70M
YoY Change 0.0%
% of Gross Profit 3.18%
Operating Expenses $236.9M
YoY Change 64.97%
Operating Profit $217.1M
YoY Change -331.45%
Interest Expense $17.90M
YoY Change -288.42%
% of Operating Profit 8.25%
Other Income/Expense, Net
YoY Change
Pretax Income $199.2M
YoY Change -291.54%
Income Tax $72.70M
% Of Pretax Income 36.5%
Net Earnings $127.2M
YoY Change -287.33%
Net Earnings / Revenue 10.87%
Basic Earnings Per Share $2.09
Diluted Earnings Per Share $2.05
COMMON SHARES
Basic Shares Outstanding 60.90M shares
Diluted Shares Outstanding 62.00M shares

Balance Sheet

Concept 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $122.4M
YoY Change 55.33%
Cash & Equivalents $122.4M
Short-Term Investments
Other Short-Term Assets $169.4M
YoY Change -49.73%
Inventory $601.6M
Prepaid Expenses
Receivables $899.0M
Other Receivables $0.00
Total Short-Term Assets $2.027B
YoY Change 69.45%
LONG-TERM ASSETS
Property, Plant & Equipment $387.8M
YoY Change -0.84%
Goodwill $309.1M
YoY Change
Intangibles $311.8M
YoY Change
Long-Term Investments
YoY Change
Other Assets $34.40M
YoY Change -3.37%
Total Long-Term Assets $1.043B
YoY Change -1.52%
TOTAL ASSETS
Total Short-Term Assets $2.027B
Total Long-Term Assets $1.043B
Total Assets $3.070B
YoY Change 36.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $346.1M
YoY Change 66.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $227.8M
YoY Change 35.19%
Total Short-Term Liabilities $1.012B
YoY Change 51.74%
LONG-TERM LIABILITIES
Long-Term Debt $1.241B
YoY Change 80.56%
Other Long-Term Liabilities $226.4M
YoY Change 1.98%
Total Long-Term Liabilities $1.468B
YoY Change 61.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.012B
Total Long-Term Liabilities $1.468B
Total Liabilities $2.480B
YoY Change 57.3%
SHAREHOLDERS EQUITY
Retained Earnings $620.1M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $364.4M
YoY Change
Treasury Stock Shares 7.100M shares
Shareholders Equity $589.7M
YoY Change
Total Liabilities & Shareholders Equity $3.070B
YoY Change 36.12%

Cashflow Statement

Concept 2012 Q1
OPERATING ACTIVITIES
Net Income $127.2M
YoY Change -287.33%
Depreciation, Depletion And Amortization $14.70M
YoY Change 0.0%
Cash From Operating Activities -$419.3M
YoY Change 147.08%
INVESTING ACTIVITIES
Capital Expenditures -$9.300M
YoY Change -66.9%
Acquisitions
YoY Change
Other Investing Activities $500.0K
YoY Change
Cash From Investing Activities -$8.800M
YoY Change -68.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 421.4M
YoY Change 126.19%
NET CHANGE
Cash From Operating Activities -419.3M
Cash From Investing Activities -8.800M
Cash From Financing Activities 421.4M
Net Change In Cash -6.700M
YoY Change -41.74%
FREE CASH FLOW
Cash From Operating Activities -$419.3M
Capital Expenditures -$9.300M
Free Cash Flow -$410.0M
YoY Change 189.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
152300000 USD
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
346100000 USD
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
327500000 USD
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
330900000 USD
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
713900000 USD
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
899000000 USD
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
542600000 USD
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
565900000 USD
CY2012Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
534400000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-87300000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-86400000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-78500000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
5400000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
4900000 USD
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10500000 USD
CY2012Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9800000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13300000 USD
CY2013Q1 us-gaap Assets
Assets
2896900000 USD
CY2012Q3 us-gaap Assets
Assets
2074400000 USD
CY2012Q1 us-gaap Assets
Assets
3069700000 USD
CY2012Q3 us-gaap Assets Current
AssetsCurrent
1000000000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
2026600000 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
1836700000 USD
CY2013Q1 us-gaap Business Acquisition Cost Of Acquired Entity Purchase Price
BusinessAcquisitionCostOfAcquiredEntityPurchasePrice
7200000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
131900000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122400000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130900000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99100000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-32800000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8500000 USD
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.300
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.325
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.600
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.650
CY2012Q1 us-gaap Common Stock Including Additional Paid In Capital
CommonStockIncludingAdditionalPaidInCapital
412500000 USD
CY2012Q3 us-gaap Common Stock Including Additional Paid In Capital
CommonStockIncludingAdditionalPaidInCapital
408600000 USD
CY2013Q1 us-gaap Common Stock Including Additional Paid In Capital
CommonStockIncludingAdditionalPaidInCapital
402700000 USD
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61700000 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61300000 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61100000 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61700000 shares
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61100000 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61300000 shares
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
128900000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33200000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
104200000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52800000 USD
CY2012Q1 us-gaap Contract Revenue Cost
ContractRevenueCost
5000000 USD
us-gaap Contract Revenue Cost
ContractRevenueCost
10000000 USD
CY2013Q1 us-gaap Contract Revenue Cost
ContractRevenueCost
5000000 USD
us-gaap Contract Revenue Cost
ContractRevenueCost
10000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
815500000 USD
CY2013Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
640800000 USD
CY2012Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
708500000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
882500000 USD
us-gaap Debt Instrument Covenant Compliance
DebtInstrumentCovenantCompliance
The Company was in compliance with the terms of all debt covenants at March 30, 2013.
us-gaap Depreciation
Depreciation
25400000 USD
us-gaap Depreciation
Depreciation
27400000 USD
CY2012Q3 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-27800000 USD
CY2012Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-23600000 USD
CY2013Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-18300000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.60
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1400000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5700000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.371
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.356
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.369
CY2012Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3650
CY2013Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
15300000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M
CY2013Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2500000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3400000 USD
CY2012Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2800000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3300000 USD
CY2013Q1 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
0 USD
CY2012Q1 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
USD
CY2012Q3 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
0 USD
CY2013Q1 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2012Q1 us-gaap Equity Method Investments
EquityMethodInvestments
USD
CY2012Q3 us-gaap Equity Method Investments
EquityMethodInvestments
USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
700000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4800000 USD
CY2013Q1 us-gaap Fees And Commissions Other
FeesAndCommissionsOther
27400000 USD
us-gaap Fees And Commissions Other
FeesAndCommissionsOther
27400000 USD
us-gaap Fees And Commissions Other
FeesAndCommissionsOther
33400000 USD
CY2012Q1 us-gaap Fees And Commissions Other
FeesAndCommissionsOther
33400000 USD
CY2012Q1 us-gaap Goodwill
Goodwill
309100000 USD
CY2013Q1 us-gaap Goodwill
Goodwill
314500000 USD
CY2012Q3 us-gaap Goodwill
Goodwill
309400000 USD
us-gaap Gross Profit
GrossProfit
487300000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
378700000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
461700000 USD
us-gaap Gross Profit
GrossProfit
409800000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
53400000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
99900000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
126500000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
31600000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
84900000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
199200000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
50100000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
155200000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.08
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.88
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.62
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.51
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.86
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.04
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.51
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.60
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-700000 USD
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-100000 USD
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-700000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-100000 USD
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
100000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
700000 USD
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
700000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-100000 USD
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2013Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2012Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31500000 USD
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
72700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18500000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55300000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-36100000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13300000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
192000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
201200000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
807400000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
638800000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
213300000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
201200000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
132600000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
78000000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
3400000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
8300000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
38100000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25500000 USD
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-4100000 USD
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-11100000 USD
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
307100000 USD
CY2012Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
311800000 USD
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
299200000 USD
CY2012Q1 us-gaap Interest Expense
InterestExpense
17900000 USD
us-gaap Interest Expense
InterestExpense
33200000 USD
us-gaap Interest Expense
InterestExpense
31100000 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
17900000 USD
us-gaap Interest Paid Net
InterestPaidNet
30700000 USD
us-gaap Interest Paid Net
InterestPaidNet
27200000 USD
CY2012Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
397100000 USD
CY2013Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
410300000 USD
CY2012Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
224600000 USD
CY2012Q3 us-gaap Inventory Net
InventoryNet
414900000 USD
CY2012Q1 us-gaap Inventory Net
InventoryNet
601600000 USD
CY2013Q1 us-gaap Inventory Net
InventoryNet
613000000 USD
CY2012Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
161000000 USD
CY2012Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
142000000 USD
CY2013Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
149100000 USD
CY2013Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
18500000 USD
CY2012Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
21000000 USD
CY2012Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
26500000 USD
CY2012Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
48300000 USD
CY2012Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
43500000 USD
CY2013Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
53600000 USD
CY2013Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
23700000 USD
CY2012Q3 us-gaap Liabilities
Liabilities
1472500000 USD
CY2013Q1 us-gaap Liabilities
Liabilities
2290000000 USD
CY2012Q1 us-gaap Liabilities
Liabilities
2480000000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3069700000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2896900000 USD
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2074400000 USD
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1012400000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
433600000 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
888200000 USD
CY2013Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
918800000 USD
CY2013Q1 us-gaap Long Term Debt
LongTermDebt
1371000000 USD
CY2012Q3 us-gaap Long Term Debt
LongTermDebt
782600000 USD
CY2012Q1 us-gaap Long Term Debt
LongTermDebt
1469000000 USD
CY2012Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1500000 USD
CY2013Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
208000000 USD
CY2012Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
227800000 USD
CY2012Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
781100000 USD
CY2013Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1163000000 USD
CY2012Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1241200000 USD
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONTINGENCIES</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management regularly evaluates the Company&#8217;s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers&#8217; compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance reserves are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, its assessment of contingencies is reasonable and related reserves, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company&#8217;s financial condition, results of operations or cash flows. The Company's identified contingencies include the matters set out below.</font></div><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Regulatory Matters</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;30, 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;"> was accrued in the &#8220;Other liabilities&#8221; line in the Condensed Consolidated Balance Sheet for compliance-related environmental actions, the majority of which is for site remediation. The amounts accrued are believed to be adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.</font></div><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the sale of wild bird food products that were the subject of a voluntary recall in 2008, the Company has been named as a defendant in four putative class actions filed on and after June 27, 2012, which have now been consolidated in the United States District Court for the Southern District of California as </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">In re Morning Song Bird Food Litigation</font><font style="font-family:inherit;font-size:10pt;">, Lead Case No. 3:12-cv-01592-JAH-RBB. The plaintiffs allege various statutory and common law claims associated with the Company's sale of wild bird food products and a plea agreement entered into in previously pending government proceedings associated with such sales. The plaintiffs seek on behalf of themselves and various purported class members monetary damages, restitution, injunctive relief, declaratory relief, attorney's fees, interest and costs. The Company intends to vigorously defend the consolidated action. Given the early stages of the action, the Company cannot make a determination as to whether it could have a material effect on the Company's financial condition, results of operations or cash flows and has not recorded any accruals with respect thereto.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company&#8217;s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs&#8217; contacts with the Company or its products. The Company believes that the claims against it are without merit and is vigorously defending against them. It is not currently possible to reasonably estimate a probable loss, if any, associated with these cases and, accordingly, no reserves have been recorded in the Company&#8217;s Consolidated Financial Statements. The Company is reviewing agreements and policies that may provide insurance coverage or indemnity as to these claims and is pursuing coverage under some of these agreements and policies, although there can be no assurance of the results of these efforts. There can be no assurance that these cases, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company&#8217;s financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company&#8217;s financial condition, results of operations or cash flows.</font></div></div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
635700000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
555900000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25200000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37700000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-620400000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-545300000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
127200000 USD
us-gaap Net Income Loss
NetIncomeLoss
53300000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
100000000 USD
us-gaap Net Income Loss
NetIncomeLoss
32300000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
173100000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
217100000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
118100000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
81200000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
400000 USD
CY2013Q1 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
200000 USD
CY2012Q1 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
200000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
400000 USD
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30500000 USD
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34400000 USD
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28700000 USD
CY2013Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
3000000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
4200000 USD
CY2012Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
200000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
2100000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
1600000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
2300000 USD
CY2012Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
2900000 USD
CY2013Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
2400000 USD
CY2013Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1200000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4900000 USD
CY2012Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1400000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4900000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-500000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
900000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4200000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1700000 USD
CY2012Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
438500000 USD
CY2013Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
352700000 USD
CY2012Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
279800000 USD
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
238800000 USD
CY2012Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
226400000 USD
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
257800000 USD
CY2013Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2012Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
8800000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-3000000 USD
CY2013Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1500000 USD
CY2012Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
700000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2600000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1300000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
17500000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
40600000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
37200000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3200000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25700000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34600000 USD
CY2012Q3 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
0 USD
CY2013Q1 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
252700000 USD
CY2012Q1 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
234200000 USD
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
158000000 USD
CY2012Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
122300000 USD
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
169400000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1166800000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1705600000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2700000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12400000 USD
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
387800000 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
417800000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427400000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
34600000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
41200000 USD
CY2012Q1 us-gaap Reimbursement Revenue
ReimbursementRevenue
23300000 USD
CY2013Q1 us-gaap Reimbursement Revenue
ReimbursementRevenue
20900000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1032400000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
572900000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
800000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
5300000 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
4600000 USD
CY2012Q3 us-gaap Restructuring Reserve
RestructuringReserve
10200000 USD
CY2013Q1 us-gaap Restructuring Reserve
RestructuringReserve
6300000 USD
CY2012Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
5100000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
7400000 USD
CY2013Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
100000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
-300000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
622200000 USD
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
620100000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
630200000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1225400000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1370000000 USD
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1019600000 USD
CY2012Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1170400000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8500000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7300000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6600000 USD
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
236900000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
359500000 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
207000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
331500000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8900000 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
26500000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3200000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2100000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P3Y7M
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
17000000 USD
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
15200000 USD
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
7800000 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
401200000 USD
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
589700000 USD
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
601900000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
606900000 USD
CY2012Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
6800000 shares
CY2013Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
6500000 shares
CY2012Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
7100000 shares
CY2013Q1 us-gaap Treasury Stock Value
TreasuryStockValue
331600000 USD
CY2012Q1 us-gaap Treasury Stock Value
TreasuryStockValue
364400000 USD
CY2012Q3 us-gaap Treasury Stock Value
TreasuryStockValue
349600000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Use of Estimates</font></div><div style="line-height:120%;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and related disclosures. Although these estimates are based on management&#8217;s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.</font></div></div>
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62300000 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60600000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61500000 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60900000 shares
smg Aggregate Stock Repurchase Program Authorized Repurchase Amount
AggregateStockRepurchaseProgramAuthorizedRepurchaseAmount
700000000 USD
CY2012Q1 smg Commission Income Expense Net
CommissionIncomeExpenseNet
28200000 USD
CY2013Q1 smg Commission Income Expense Net
CommissionIncomeExpenseNet
22200000 USD
smg Commission Income Expense Net
CommissionIncomeExpenseNet
17000000 USD
smg Commission Income Expense Net
CommissionIncomeExpenseNet
23000000 USD
smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
200000 USD
CY2012Q1 smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
200000 USD
CY2013Q1 smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
0 USD
smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
0 USD
smg Cost Of Sales Impairment Restructuring And Other Charges
CostOfSalesImpairmentRestructuringAndOtherCharges
0 USD
smg Cost Of Sales Impairment Restructuring And Other Charges
CostOfSalesImpairmentRestructuringAndOtherCharges
100000 USD
CY2013Q1 smg Cost Of Sales Impairment Restructuring And Other Charges
CostOfSalesImpairmentRestructuringAndOtherCharges
100000 USD
CY2012Q1 smg Cost Of Sales Impairment Restructuring And Other Charges
CostOfSalesImpairmentRestructuringAndOtherCharges
0 USD
smg Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Share Based Awards And Vesting Of Restricted Stock
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfShareBasedAwardsAndVestingOfRestrictedStock
1100000 USD
smg Gain Loss On Sale Of Long Lived Assets
GainLossOnSaleOfLongLivedAssets
0 USD
smg Gain Loss On Sale Of Long Lived Assets
GainLossOnSaleOfLongLivedAssets
100000 USD
smg Grant Of Share Based Compensation Awards
GrantOfShareBasedCompensationAwards
708243.000000 shares
smg Grant Of Share Based Compensation Awards
GrantOfShareBasedCompensationAwards
336833.000000 shares
CY2013Q1 smg Intercompany Assets
IntercompanyAssets
0 USD
CY2012Q1 smg Intercompany Assets
IntercompanyAssets
USD
CY2012Q3 smg Intercompany Assets
IntercompanyAssets
USD
CY2013Q1 smg Intercompany Liabilities
IntercompanyLiabilities
0 USD
CY2012Q1 smg Intercompany Liabilities
IntercompanyLiabilities
USD
CY2012Q3 smg Intercompany Liabilities
IntercompanyLiabilities
0 USD
CY2013Q1 smg Interest Coverage Ratio
InterestCoverageRatio
4.45
CY2013Q1 smg Leverage Ratio
LeverageRatio
3.24
CY2013Q1 smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
43100000 USD
CY2012Q1 smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
51500000 USD
smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
51600000 USD
smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
64200000 USD
smg Payments For Proceeds From Intercompany Advances From Financing Activities
PaymentsForProceedsFromIntercompanyAdvancesFromFinancingActivities
0 USD
smg Payments For Proceeds From Intercompany Advances From Financing Activities
PaymentsForProceedsFromIntercompanyAdvancesFromFinancingActivities
USD
smg Payments For Restructuring And Other
PaymentsForRestructuringAndOther
4100000 USD
smg Proceeds From Sale Of Long Lived Assets
ProceedsFromSaleOfLongLivedAssets
500000 USD
smg Proceeds From Sale Of Long Lived Assets
ProceedsFromSaleOfLongLivedAssets
100000 USD
CY2013Q1 smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
0 USD
smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
3600000 USD
CY2012Q1 smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
3300000 USD
smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
0 USD
CY2013Q1 smg Regulatory Matters Other Liabilities
RegulatoryMattersOtherLiabilities
3700000 USD
smg Restructuring Reserve Period Expense And Other Related Charges
RestructuringReservePeriodExpenseAndOtherRelatedCharges
200000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-03-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000825542
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61703557 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
SCOTTS MIRACLE-GRO CO
dei Trading Symbol
TradingSymbol
SMG

Files In Submission

Name View Source Status
0001546380-13-000012-index-headers.html Edgar Link pending
0001546380-13-000012-index.html Edgar Link pending
0001546380-13-000012.txt Edgar Link pending
0001546380-13-000012-xbrl.zip Edgar Link pending
exhibit106smg03302013q2f13.htm Edgar Link pending
exhibit108smg03302013q2f13.htm Edgar Link pending
exhibit311smg03302013q2f13.htm Edgar Link pending
exhibit312smg03302013q2f13.htm Edgar Link pending
exhibit32smg03302013q2f13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smg-0330201310q2f13.htm Edgar Link pending
smg-20130330.xml Edgar Link completed
smg-20130330.xsd Edgar Link pending
smg-20130330_cal.xml Edgar Link unprocessable
smg-20130330_def.xml Edgar Link unprocessable
smg-20130330_lab.xml Edgar Link unprocessable
smg-20130330_pre.xml Edgar Link unprocessable